American International Group’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,753
Closed -$132K 2527
2024
Q1
$132K Sell
24,753
-212
-0.8% -$997 ﹤0.01% 2370
2023
Q4
$107K Sell
24,965
-101
-0.4% -$310 ﹤0.01% 2528
2023
Q3
$98.3K Buy
25,066
+891
+4% +$5.84K ﹤0.01% 2526
2023
Q2
$245K Buy
24,175
+6,130
+34% +$64.9K ﹤0.01% 2056
2023
Q1
$184K Buy
18,045
+360
+2% +$4.12K ﹤0.01% 2160
2022
Q4
$166K Sell
17,685
-64
-0.4% -$903 ﹤0.01% 2237
2022
Q3
$258K Buy
17,749
+250
+1% +$3.71K ﹤0.01% 2011
2022
Q2
$231K Buy
17,499
+5,881
+51% +$80.1K ﹤0.01% 2096
2022
Q1
$198K Sell
11,618
-347
-3% -$5.89K ﹤0.01% 2245
2021
Q4
$307K Buy
+11,965
New +$373K ﹤0.01% 2104

Other funds holding TSVT

American International Group's TSVT Position: Q2 2024 in Review

American International Group sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 24,753 shares — an estimated $132K sold.

American International Group first reported a position in TSVT in Q4 2021 and held it in 10 quarters. The position peaked at $307K in Q4 2021. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • American International Group reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 24,753 2seventy bio shares in Q2 2024, an estimated $132K.
  • American International Group first reported a position in 2seventy bio in Q4 2021 and held it in 10 quarters.
  • American International Group's 2seventy bio position peaked at $307K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.